We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Prixa, a leading health-tech company, recently raised additional US$3 million funding, led by MDI and TPTF with participation from existing investors including Siloam Hospitals Group.
Aptar Pharma is expanding its digital healthsolutions driven by the impact of COVID-19 pandemic on patients and their ability to visit their physician or hospital.